Pfizer Says Vulnerable Groups To Get Vaccine First

Dr. Scott Gottlieb discusses the timeline for vaccine availability, with emergency use authorization expected for a limited population this winter. Older adults will be prioritized, with broader availability in the spring. Pfizer and Biontech have requested FDA emergency use authorization for their vaccine, which has shown 95% efficacy.

When is the vaccine expected to be available for a limited population?

What type of authorization did Pfizer and Biontech request from the FDA?